The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis

被引：0
|
作者：
Zhi Dong Zhou
Wuan Ting Saw
Patrick Ghim Hoe Ho
Zhi Wei Zhang
Li Zeng
Ya Yin Chang
Alfred Xu Yang Sun
Dong Rui Ma
Hong Yan Wang
Lei Zhou
Kah Leong Lim
Eng-King Tan
机构：
[1] National Neuroscience Institute,Department of Neurology, Singapore General Hospital
[2] National Neuroscience Institute,Duke
[3] Signature Research Program in Neuroscience and Behavioural Disorders,NUS Graduate Medical School
[4] Singapore Eye Research Institute,Ocular Proteomics Laboratory
[5] National University of Singapore,Department of Ophthalmology, Yong Loo Lin School of Medicine
[6] Ophthalmology and Visual Sciences Academic Clinical Research Program,Developmental of Stem Cell Biology and Regenerative Medicine, Lee Kong Chian School of Medicine
[7] Duke-NUS Medical School,undefined
[8] Nanyang Technological University,undefined
来源：
Cellular and Molecular Life Sciences | 2022年 / 79卷
关键词：
Dopamine; LRRK2; Neurodegeneration; Parkinson’s disease; PINK1; Tyrosine hydroxylase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis
    Zhou, Zhi Dong
    Saw, Wuan Ting
    Ho, Patrick Ghim Hoe
    Zhang, Zhi Wei
    Zeng, Li
    Chang, Ya Yin
    Sun, Alfred Xu Yang
    Ma, Dong Rui
    Wang, Hong Yan
    Zhou, Lei
    Lim, Kah Leong
    Tan, Eng-King
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (12)
  • [2] A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson's Disease
    Tabrez, Shams
    Jabir, Nasimudeen R.
    Shakil, Shazi
    Greig, Nigel H.
    Alam, Qamre
    Abuzenadah, Adel M.
    Damanhouri, Ghazi A.
    Kamal, Mohammad A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (04) : 395 - 409
  • [3] Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease
    Yi, Ling Xiao
    Tan, Eng King
    Zhou, Zhi Dong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [4] Overview of Tyrosine Hydroxylase in Parkinson's Disease
    Zhu, Yanzhen
    Zhang, Jing
    Zeng, Yanjun
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (04) : 350 - 358
  • [5] Tyrosine hydroxylase and Parkinson's disease
    Haavik, Jan
    Toska, Karen
    MOLECULAR NEUROBIOLOGY, 1998, 16 (03) : 285 - 309
  • [6] Tyrosine hydroxylase and Parkinson's disease
    Jan Haavik
    Karen Toska
    Molecular Neurobiology, 1998, 16 (3) : 285 - 309
  • [7] Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase
    Nagatsu, Toshiharu
    Nakashima, Akira
    Watanabe, Hirohisa
    Ito, Shosuke
    Wakamatsu, Kazumasa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [8] The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
    Burbulla, Lena F.
    Krainc, Dimitri
    NEUROBIOLOGY OF DISEASE, 2019, 132
  • [9] Human tyrosine hydroxylase in Parkinson’s disease and in related disorders
    Toshiharu Nagatsu
    Akira Nakashima
    Hiroshi Ichinose
    Kazuto Kobayashi
    Journal of Neural Transmission, 2019, 126 : 397 - 409
  • [10] Human tyrosine hydroxylase in Parkinson's disease and in related disorders
    Nagatsu, Toshiharu
    Nakashima, Akira
    Ichinose, Hiroshi
    Kobayashi, Kazuto
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (04) : 397 - 409
12345